... inhibitors Acute renal failure Pharmacokinetics Pharmacodynamics Empagliflozin Canagliflozin Dapagliflozin Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a novel class of glucose-lowering agent that seems to be promising drugs, because recent studies suggest long-term cardiovascular...

.... The current study was performed to assess the pharmacokinetic and pharmacodynamic properties as well as safety of subcutaneously applied PTH-1-37 after repeated dosing in healthy subjects. Methods: This randomized, double-blind, dose-escalating, placebo and active comparator controlled study was conducted...

..., instructions or products referred to in the content or advertisements. Renal papillary necrosis Non-steroidal anti-inflammatory drugs N-phenylanthranilic acid Pharmacokinetics Renal Physiol Biochem 1989:12:406-412 © 1989 S. Kargcr A G. Basel mi]-G524/89/m24-IMOf> S2.75AI The Kinetics...

... Franz Maximilian Rasche Department of Internal Medicine II, Division of Nephrology, University Hospital of Ulm, Ulm, Germany Key Words Extracorporeal drug removal W Hemodialysis W Removed fraction W Eliminated fraction W Rebound W Valganciclovir W Ganciclovir W Pharmacokinetics W Drug dose adjustment W...

... infections. Furthermore, flucloxacillin has a high protein binding rate as for example ceftriaxone or teicoplanin – drugs which have formerly been characterized as not being dialyzable. Methods: The pharmacokinetic parameters of 4.0 g flucloxacillin every 8 h were examined in 10 intensive care patients...